Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Morning Read: Pfizer hopes recipe app will fight flight to generic Lipitor

8:45 am by | 1 Comments

Pfizer has launched an app that offers recipes from EatingWell magazine and a copy of the Lipitor $4 co-pay card as a last-ditch effort to keep people from switching to the generic version of the cholesterol drug that will be available next week. Health economist Jane Sarasohn-Kahn is not optimistic that this initial foray into a prescription drug-affiliated app will work.

Analysts at Ernst & Young and France Biotech say that companies in that sector have seen a 40% drop in funding from new venture cash, IPOs and refinancings from 2010 to 2011. The number of new biotechs created in the country dropped to only 24 in 2011, and there were 25 closures, compared to 5 the year before.

 A study of a large group of managed-care enrollees starting oral diabetes treatment found that 35% of patients did not receive the recommended first-line drug. Study co-author Dr. Niteesh K. Choudhry said that following standard guidelines for treating Type 2 diabetes could mean significant cost savings for patients, payers, and the entire healthcare system.

Halo Theraputics is using approach for its latest round of $1.1 million in funding: traditional grants, plus notes that offer a fixed return to the 12 nonprofits based on specific development milestones. The foundations are all focused on finding a treatment for Duchenne Muscular Dystrophy (DMD), a rare but debilitating muscle disease that leads to early death in young boys. Halo’s drug candidate uses an herb from Chinese medicine.

Advertisement

PCORI has announced five funding opportunities worth $96 million, including: assessment of prevention, diagnosis, and treatment options; improving healthcare systems; communication and dissemination; addressing disparities; and accelerating patient-centered and methodological research. Applications will be evaluated for alignment with eight PCORI review criteria based on PCORI’s authorizing legislation.

[Image from flickr user The.Comedian]

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Veronica Combs

By Veronica Combs

I am the editor in chief at MedCityNews.com. I started writing and editing in the print world and joined a dotcom right before the 2000 crash. I was at TechRepublic/CNET/BNET for 7 years. Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news. A year later, MedTrackAlert was acquired by HealthCentral, so I shifted to audience research. The fun of daily news and interviewing smart people brought me to MedCity News in February 2012.
Visit website | More posts by Author

1 comments
Robert Chalfant
Robert Chalfant

Lipitor "last-ditch effort"? I doubt that it's their last ditch, probably not even their 10th to the last ditch. Look for more promotions.